Click a link below to view the mailing archive as if it had been sent to you.
| 2020-01-31 12:15 | | A Cure for Cancer Might Be on the Way -- and It Could Turn Healthcare Investing Upside Down and more... |
| 2020-01-31 00:15 | | Mammoth Biosciences Raises $45 Million For Crispr Diagnostics—And Its Tech Is Already Being Used Against Coronavirus and more... |
| 2020-01-30 12:15 | | Eli Lilly cuts three cancer drugs amid Q4 clear-out and more... |
| 2020-01-30 00:15 | | Annovis Bio Gets $12M in IPO to Target Trio of Neurotoxic Proteins and more... |
| 2020-01-29 12:15 | | In coronavirus response, AI is becoming a useful tool in a global outbreak, data experts say and more... |
| 2020-01-29 00:15 | | Anti-Aging And Aesthetic Medicine: The Silent Rise Of This Multibillion Dollar Industry and more... |
| 2020-01-28 12:15 | | Pfizer Misses Q4 Earnings Forecast as UpJohn, Lyrica Revenues Slide and more... |
| 2020-01-28 00:15 | | Martin Shkreli is sued by the FTC and NY attorney general for illegally cornering a market and more... |
| 2020-01-27 12:15 | | Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie and more... |
| 2020-01-27 00:15 | | A Biotech VC’s Prescription For What Ails Pharma and more... |
| 2020-01-26 00:15 | | Abbott's Brain Stimulation System Approved to Treat Parkinson's and more... |
| 2020-01-25 00:15 | | FDA decision nears on Aimmune's contested peanut allergy drug |
| 2020-01-24 12:15 | | Where Will Intercept Pharmaceuticals Be in 5 Years? and more... |
| 2020-01-24 00:15 | | FDA Warns of Cyber Risks With Certain GE Devices and more... |
| 2020-01-23 12:15 | | Merck KGaA spinout iOnctura raises cash for cancer trials and more... |
| 2020-01-23 00:15 | | Moderna, federal researchers kick off vaccine work against deadly new coronavirus and more... |
| 2020-01-22 12:15 | | Merck turns to contract manufacturers to help with Gardasil supply, plans 2023 plant openings and more... |
| 2020-01-22 00:15 | | FDA Approves First-Ever Treatment for Thyroid Eye Disease and more... |
| 2020-01-21 12:15 | | Almost 50 Non-Oncology Drugs Found to Kill Cancer Cells and more... |
| 2020-01-21 00:15 | | Novo Nordisk’s quiet entry into the year of Alzheimer’s and more... |
| 2020-01-20 12:15 | | I Have a Dream… Five Dreams for Biotech and more... |
| 2020-01-20 00:15 | | Insys bankruptcy plan gets court OK and more... |
| 2020-01-19 00:15 | | After big year, RNAi drugmakers compete to prove what comes next and more... |
| 2020-01-18 00:15 | | The truth about JPM: Less is more and more... |
| 2020-01-17 12:15 | | After CES, Twitter exec highlights gadgets, gossip and buzz for pharma and more... |
| 2020-01-17 00:15 | | BioMarin Considers $3 Million Price Tag for New Hemophilia Gene Therapy and more... |
| 2020-01-16 12:15 | | Government spending bill tweak means 3 more NDAs will become BLAs, FDA says and more... |
| 2020-01-16 00:15 | | Novartis' David Lennon on next steps for AveXis, selling Zolgensma's price to the public and more... |
| 2020-01-15 12:15 | | Nektar pulls NDA for pain drug after unanimous AdComm rejection and more... |
| 2020-01-15 00:15 | | 23andMe’s First Drug Candidate Licensed to Spanish Pharma Company and more... |
| 2020-01-14 12:15 | | JPM: Already prepping for Alzheimer's launch, Biogen scouts 'top talent' and talks pricing and more... |
| 2020-01-14 00:15 | | JPM kickoff: Gilead's deal ideal, Novartis' image-polishing, Teva's shutdown tally and one CEO's word on another and more... |
| 2020-01-13 12:15 | | JP Morgan Preview: Small, Medium and Large, with a Lot of M&A Speculation and more... |
| 2020-01-13 00:15 | | A Pharma Startup Launches With $200 Million In Funding And A Strategy To Make Drugs Faster, Cheaper and more... |
| 2020-01-12 00:15 | | Portola's stock falls on weak Andexxa sales and more... |
| 2020-01-11 12:15 | | Bristol-Myers confident of approvals linked to higher Celgene investor payout: Bristol executive and more... |
| 2020-01-11 00:15 | | VBI Vaccines announces second pivotal phase 3 study of Sci-B-Vac meets primary and secondary endpoints and more... |
| 2020-01-10 12:15 | | Eli Lilly Bags Dermatology Company Dermira for $1.1 Billion and more... |
| 2020-01-10 00:15 | | Lilly, Strateos open remote-controlled robotic research lab in San Diego and more... |
| 2020-01-09 12:15 | | Merck's Blockbuster Drug Wins Key New FDA Approval and more... |
| 2020-01-09 00:15 | | Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy and more... |
| 2020-01-08 12:15 | | Here’s Why Illumina Shares Barely Budged When It Gave Up On Its Takeover to The Tune Of $98 Million and more... |
| 2020-01-08 00:15 | | 'Burner' phones and Ariad secrets: Goldman Sachs banker pleads guilty for his role in global insider trading ring and more... |
| 2020-01-07 12:15 | | Could artificial intelligence replace pharma reps? and more... |
| 2020-01-07 00:15 | | GSK's plan to take over the HIV drug market hasn't worked out and more... |
| 2020-01-06 12:15 | | Novartis, Merck and Allergan raise drug prices to start 2020, joining Big Pharma peers and more... |
| 2020-01-06 00:15 | | CMS delays clinical lab fee schedule data reporting, cuts capped at 15% for 2021 and more... |
| 2020-01-05 00:15 | | 20 Private Medtech Companies to Watch in 2020 and more... |
| 2020-01-04 00:15 | | Illumina scraps $1.2B PacBio takeover amid regulatory pushback and more... |
| 2020-01-03 12:15 | | FDA rushed to approve 48 drugs in 2019, sometimes way ahead of schedule. Could that be dangerous? and more... |
| 2020-01-03 00:15 | | 3 Blockbuster Cancer Drug Launches to Watch in 2020 and more... |
| 2020-01-02 12:15 | | Regeneron to lay off field staffers as it restructures Sanofi partnership and more... |
| 2020-01-02 00:15 | | Antibiotics maker Melinta files for Chapter 11 bankruptcy and more... |
